172 related articles for article (PubMed ID: 908018)
21. Effects of the immunomodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rats.
Chung JG; Chang HL; Yeh CC; Lu HF; Chang CC; Tsai HD
Anticancer Res; 2000; 20(1A):467-73. PubMed ID: 10769698
[TBL] [Abstract][Full Text] [Related]
22. Syntheses of DNA adducts of two heterocyclic amines, 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAalphaC) and 2-amino-9H-pyrido[2,3-b]indole (AalphaC) and identification of DNA adducts in organs from rats dosed with MeAalphaC.
Frederiksen H; Frandsen H; Pfau W
Carcinogenesis; 2004 Aug; 25(8):1525-33. PubMed ID: 15059926
[TBL] [Abstract][Full Text] [Related]
23. Spectroscopic study of the effects of C-alkylation of N-acetoxy-N-acetyl-2-aminofluorene on some properties of the carcinogen-modified DNA.
Spodheim-Maurizot M; Durand M; Loukakou PE; Saint-Ruf G
Cancer Biochem Biophys; 1983; 6(4):261-7. PubMed ID: 6616432
[TBL] [Abstract][Full Text] [Related]
24. Recognition and repair of 2-aminofluorene- and 2-(acetylamino)fluorene-DNA adducts by UVRABC nuclease.
Pierce JR; Case R; Tang MS
Biochemistry; 1989 Jul; 28(14):5821-6. PubMed ID: 2775737
[TBL] [Abstract][Full Text] [Related]
25. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene.
Beland FA; Dooley KL; Jackson CD
Cancer Res; 1982 Apr; 42(4):1348-54. PubMed ID: 6949639
[TBL] [Abstract][Full Text] [Related]
26. Energy minimized structures of carcinogen-DNA adducts: 2-acetylaminofluorene and 2-aminofluorene.
Hingerty BE; Broyde S
J Biomol Struct Dyn; 1986 Dec; 4(3):365-72. PubMed ID: 3271449
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic insights into replication across from bulky DNA adducts: a mutant polymerase I allows an N-acetyl-2-aminofluorene adduct to be accommodated during DNA synthesis.
Lone S; Romano LJ
Biochemistry; 2003 Apr; 42(13):3826-34. PubMed ID: 12667073
[TBL] [Abstract][Full Text] [Related]
28. Structure and stability of duplex DNA containing the 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene (dG(N2)-AAF) lesion: a bulky adduct that persists in cellular DNA.
Zaliznyak T; Bonala R; Johnson F; de Los Santos C
Chem Res Toxicol; 2006 Jun; 19(6):745-52. PubMed ID: 16780352
[TBL] [Abstract][Full Text] [Related]
29. The biological activity of single-stranded phi X174 DNA, modified by N-hydroxy-2-aminofluorene, is inhibited by guanine imidazole ring-opening of the major, non-lethal aminofluorene-DNA adduct.
Lutgerink JT; Retèl J; Westra JG; Welling MC; Loman H; Kriek E
Carcinogenesis; 1986 Aug; 7(8):1359-64. PubMed ID: 2942308
[TBL] [Abstract][Full Text] [Related]
30. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
Hatcher JF; Swaminathan S
Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
[TBL] [Abstract][Full Text] [Related]
31. Deoxyribonucleic acid strandedness. Partial characterization of the antigenic regions binding antibodies in lupus erythematosus serum.
Samaha RJ; Irvin WS
J Clin Invest; 1975 Aug; 56(2):446-57. PubMed ID: 125288
[TBL] [Abstract][Full Text] [Related]
32. Comparative survival of aminobiphenyl- and aminofluorene-substituted plasmid DNA in Escherichia coli Uvr endonuclease deficient strains.
Tamura N; King CM
Carcinogenesis; 1990 Apr; 11(4):535-40. PubMed ID: 2182216
[TBL] [Abstract][Full Text] [Related]
33. N-2-fluorenylacetamide-induced conformational and functional damage to DNA.
Grunberger D
Natl Cancer Inst Monogr; 1981 Dec; (58):193-9. PubMed ID: 7341976
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of N-(guanin-8-yl)-N-acetyl-2-aminofluorene and N-(guanin-8-yl)-2-aminofluorene in modified DNA by hydrolysis in trifluoroacetic acid and high pressure liquid chromatography.
Westra JG; Visser A
Cancer Lett; 1979 Dec; 8(2):155-62. PubMed ID: 555872
[TBL] [Abstract][Full Text] [Related]
35. Measurement of O6-ethyldeoxyguanosine and N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene in DNA by high-sensitive enzyme immunoassays.
Van Der Laken CJ; Hagenaars AM; Hermsen G; Kriek E; Kuipers AJ; Nagel J; Scherer E; Welling M
Carcinogenesis; 1982; 3(5):569-72. PubMed ID: 7094214
[TBL] [Abstract][Full Text] [Related]
36. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
Flammang TJ; Yerokun T; Bryant MS; Couch LH; Kirlin WG; Lee KJ; Ogolla F; Ferguson RJ; Talaska G; Hein DW
J Pharmacol Exp Ther; 1992 Feb; 260(2):865-71. PubMed ID: 1738128
[TBL] [Abstract][Full Text] [Related]
37. Probing the conformational heterogeneity of the acetylaminofluorene-modified 2'-deoxyguanosine and DNA by 19F NMR spectroscopy.
Cho BP; Zhou L
Biochemistry; 1999 Jun; 38(23):7572-83. PubMed ID: 10360955
[TBL] [Abstract][Full Text] [Related]
38. Solution structure of the aminofluorene [AF]-intercalated conformer of the syn-[AF]-C8-dG adduct opposite dC in a DNA duplex.
Mao B; Hingerty BE; Broyde S; Patel DJ
Biochemistry; 1998 Jan; 37(1):81-94. PubMed ID: 9425028
[TBL] [Abstract][Full Text] [Related]
39. Structural identification of the pyrimidine derivatives formed from N-(deoxyguanosin-8-yl)-2-aminofluorene in aqueous solution at alkaline pH.
Kriek E; Westra JG
Carcinogenesis; 1980 Jun; 1(6):459-68. PubMed ID: 7273279
[TBL] [Abstract][Full Text] [Related]
40. In vitro binding of N-acetoxy-N-2-acetylaminofluorene to DNA in chromatin.
Metzger G; Daune MP
Cancer Res; 1975 Oct; 35(10):2738-42. PubMed ID: 1157048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
